does retatrutide cause weight loss How Work? Doctor Explains Why It's So Effective How Long Does It Take
Description
The FDA approved the first GLP-1 agonist, exenatide, to treat type 2 diabetes in 2005
Participants with type 2 diabetes experienced slightly lower weight loss (19.7% versus 22.4% for non diabetic participants) but gained substantial metabolic benefits
30 Our results found that the increases in diabetes-specific and all-cause costs shown for the group taking GLP-1 RAs were largely attributable to the higher drug acquisition costs of the GLP-1 RAs
In other words, the change acknowledges obesity as a medical factor contributing to chronic illness without yet classifying it as a stand-alone disease for coverage
Listen to this part
